	Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review. Front Oncol Mou Y, Han L, Yu J, Shen H, Li H, Xu L, Li Q. PMID: 42358547 [PubMed - in process]
	On the Progression From Early-to Late-Stage Melanoma: A Potential Sequence of Molecular Events Using Data From Droplet Digital PCR and Array Comparative Genomic Hybridization, A Pilot Study. Am J Dermatopathol McFadden JR, Htoo A, Chaudhari AS, Stevanovic M, Tsongalis GJ, Hughes EG, Sriharan A. PMID: 42358058 [PubMed - as supplied by publisher]
	Observational Study Profiling the Immune Microenvironment of Pregnancy-associated Melanoma. Am J Dermatopathol Kazmi M, Melloy MP, Abukhadra S, Terrell JR, Li Q, Zhu G, Tartar D, Keegan T, Maverakis E, Kiuru M. PMID: 42358002 [PubMed - as supplied by publisher]
	Immunotherapy for Melanoma: A Concise Clinical Review for Australasian Practice. Australas J Dermatol Stacy A, Wynn L, Seebacher N. PMID: 42357917 [PubMed - as supplied by publisher]
	Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications. Pharmaceuticals (Basel) Bertolucci RV, Klein B, Pase CC, de Melo VC, Bagatini MD. PMID: 42356529 [PubMed - in process]
	The Influence of Dietary and Physical Exercise Habits on Melanoma Risk: A Case-Control Study. Nutrients Crespí-Payeras F, Moll-Amengual R, Calbet-Llopart N, Mateu J, Potrony M, Carrera C, Iglesias P, Tell-Martí G, Moral TT, Puig S. PMID: 42356305 [PubMed - in process]
	Current and Future Perspectives in Mohs Micrographic Surgery for Non-Melanoma Skin Cancers: A Narrative Review. J Clin Med Paradisi A, Brunetti F, Jeha GM, Tolkachjov SN. PMID: 42355922 [PubMed - in process]
	Efficacy and Safety of PD-1 Inhibitor-Based Regimens in Patients with Melanoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med Kouris NI, Filippatos C, Lallas K, Spyropoulou S, Malandrakis P, Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I. PMID: 42355889 [PubMed - in process]
	Predicting Response to Immune Checkpoint Inhibitors in Melanoma: Emerging Approaches in Digital Pathology, Spatial Profiling and Machine Learning. Int J Mol Sci Banaszek J, B, Bara, Czajka A, Ciesielska D, Kleinrok J, Paj, Korolczuk A, Mazur M, Rusztyn K. PMID: 42352966 [PubMed - in process]
	Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study. Cancers (Basel) Steenhuis EGM, van Disseldorp LM, Jacobs FJC, van Schayk N, Suijkerbuijk K, Louwman M, d'Hooghe JNS, Damhuis RAM, van Geffen WH. PMID: 42352551 [PubMed - in process]
	Real-World Outcomes of Nivolumab Plus Ipilimumab in Metastatic Melanoma: A Stratified Analysis of First- and Second-Line Treatment. Cancers (Basel) Iurchenkov A, Danilova A, Shilo P, Stoliarov V, Rakhmanova P, Kanner I, Basharina A, Stroyakovskiy D. PMID: 42352526 [PubMed - in process]
	Biomarkers in Melanoma: Updates in Prognosis and Management. Cancers (Basel) Crosby B, Guerra M, Crosby A, Linza B, Lourdault K, Essner R. PMID: 42352524 [PubMed - in process]
	Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma. Cancers (Basel) Papadopoulos N, Del Vecchio M, Spagnoletti A, Pigozzo J, Piccin L, Minisini A, Pravisano F, Roccuzzo G, Fava P, Cimminiello C. PMID: 42352510 [PubMed - in process]
	Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now? Cancers (Basel) Piccin L, Guarneri V, Del Vecchio M, Spagnoletti A, Fava P, Roccuzzo G, Cimminiello C, Papadopoulos N, Minisini A, Costa J, Pigozzo J. PMID: 42352494 [PubMed - in process]
	From Primary Melanoma to Metastatic Evolution: AI-Powered Pathology Integrated with Functional Analysis and Clinical Metadata Improving Treatment Prediction. Cancers (Basel) Fülöp L, Szadai L, Szigeti B, Christersson L, Oskolas H, Horvatovich P, Fernandez-Coto DL, Malm J, Wieslander E, Baldetorp B, Encarnación-Guevara S, Szasz AM, Nemeth IB, Fenyö D, Gil J, Marko-Varga G. PMID: 42352484 [PubMed - in process]
	B7-H6/NKp30 Axis in Melanoma: Translational Rationale, Evidence Gaps, and Therapeutic Considerations. Biomolecules Truong-Balderas KM, Chang RC, Lasalle C, Gao Y, Nowak NC, Amber KT, Mansini AP. PMID: 42352328 [PubMed - in process]
	Updates on intratumoral therapies in melanoma. Cancer Ma VT, Steimle AK, Patel JD, Burkey C, Moser JC, Javed A, Tul Rehman H, Seker ME, Birbrair A, Ozkan OS, Albertini MR, Najjar YG, Kulkarni RP. PMID: 42349466 [PubMed - in process]
	Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities. BioDrugs Wilson RJ, Ramlogan-Steel CA, Deasy WJ, Greenstein SJ, Layton CJ, Steel JC. PMID: 42348124 [PubMed - as supplied by publisher]
	Quality by Design-Endorsed Nilotinib-Laden Liposomal Gel for Enhanced Dermal Delivery in Melanoma Management: Fabrication, Optimization, In Silico, In Vitro, and Ex Vivo Studies. ACS Appl Bio Mater Hedaoo A, Khairnar P, Vambhurkar G, Sahane P, Kumar R, Sharma A, Sharma A, Srivastava S. PMID: 42347778 [PubMed - as supplied by publisher]
	MRI-Based Radiomics and Artificial Intelligence for Prediction of Recurrence and Prognostic Outcomes in Oral Tongue Squamous Cell Carcinoma: A Systematic Review with Functional Meta-Synthesis. Med Sci (Basel) Ardila CM, Pineda-Vélez E, Vivares-Builes AM, Díaz-Laclaustra AI. PMID: 42346871 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 143407

Page 1 of 7171



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy